TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · IEX Real-Time Price · USD

89.25

+0.37 (0.42%)

At close: Apr 25, 2024, 4:00 PM

88.00

-1.25 (-1.40%)

After-hours: Apr 25, 2024, 6:57 PM EDT

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	241.62	93.46	30.26	25.64	23.6	13.02	7.69	6.21
Revenue Growth (YoY)	158.53%	208.83%	18.03%	8.62%	81.33%	69.38%	23.77%	-
Cost of Revenue	87.53	28.19	9.1	9	9.74	7.28	5.55	5.44
Gross Profit	154.09	65.27	21.16	16.64	13.86	5.73	2.14	0.77
Selling, General & Admin	119.55	69.9	38.28	24.19	23.6	12.32	7.61	8.12
Research & Development	36.06	26.81	22.3	18.83	19.87	13.66	14.96	15.64
Other Operating Expenses	27.21	0	0	0	0	0	0	0
Operating Expenses	182.82	96.71	60.59	43.02	43.47	25.97	22.56	23.75
Operating Income	-28.73	-31.44	-39.43	-26.38	-29.6	-20.24	-20.43	-22.99
Interest Expense / Income	10.79	3.73	3.87	3.99	4.35	2.72	1.07	0.98
Other Expense / Income	-12.85	1	0.88	-1.65	-0.45	0.76	-0.71	0.1
Pretax Income	-26.67	-36.17	-44.18	-28.72	-33.51	-23.72	-20.79	-24.07
Income Tax	-1.64	0.07	0.04	0.03	0.04	0.04	0.03	0
Net Income	-25.03	-36.23	-44.22	-28.75	-33.55	-23.76	-20.82	-24.07
Shares Outstanding (Basic)	33	30	28	25	14	1	5	5
Shares Outstanding (Diluted)	33	30	28	25	14	1	5	5
Shares Change	10.02%	7.02%	11.80%	73.90%	945.47%	-70.77%	3.23%	-
EPS (Basic)	-0.77	-1.23	-1.60	-1.16	-2.36	-17.48	-4.48	-5.35
EPS (Diluted)	-0.77	-1.23	-1.60	-1.16	-2.36	-17.48	-4.48	-5.35
Free Cash Flow	-164.88	-57.72	-32.38	-30.72	-32.45	-26.4	-23.36	-25.59
Free Cash Flow Per Share	-5.07	-1.95	-1.17	-1.24	-2.29	-19.43	-5.03	-5.68
Gross Margin	63.77%	69.84%	69.92%	64.88%	58.73%	44.05%	27.81%	12.34%
Operating Margin	-11.89%	-33.64%	-130.29%	-102.91%	-125.42%	-155.47%	-265.79%	-370.20%
Profit Margin	-10.36%	-38.77%	-146.11%	-112.13%	-142.12%	-182.50%	-270.96%	-387.58%
Free Cash Flow Margin	-68.24%	-61.76%	-107.01%	-119.82%	-137.48%	-202.83%	-303.98%	-412.10%
EBITDA	-6.66	-28.24	-37.66	-23.15	-27.93	-20.23	-19.09	-22.66
EBITDA Margin	-2.76%	-30.22%	-124.44%	-90.31%	-118.34%	-155.38%	-248.39%	-364.95%
Depreciation & Amortization	9.22	4.2	2.65	1.58	1.22	0.77	0.63	0.43
EBIT	-15.88	-32.44	-40.31	-24.73	-29.15	-21	-19.72	-23.09
EBIT Margin	-6.57%	-34.71%	-133.19%	-96.46%	-123.51%	-161.29%	-256.59%	-371.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).